-
Supported By:
Subscribe or Follow
Program on Corporate Governance Advisory Board
- Peter Atkins
- David Bell
- Kerry E. Berchem
- Richard Brand
- Daniel Burch
- Paul Choi
- Jesse Cohn
- Arthur B. Crozier Christine Davine
- Renata J. Ferrari
- Andrew Freedman
- Ray Garcia
- Byron Georgiou
- Joseph Hall
- Jason M. Halper William P. Mills
- David Millstone
- Theodore Mirvis
- Philip Richter
- Elina Tetelbaum
- Sebastian Tiller
- Marc Trevino Jonathan Watkins
- Steven J. Williams
HLS Faculty & Senior Fellows
Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation
Director Fiduciary Duty in Insolvency
With businesses focused on the impact of the novel coronavirus (COVID-19) pandemic on current and future liquidity, balance sheet and cash flow concerns, and an expected decline in the level and profitability of business activity in these difficult and uncertain times, in many cases attention has turned to the issue of the duties and responsibilities […]
Click here to read the complete postPolitics and Gender in the Executive Suite
In a new study placed on SSRN, Politics and Gender in the Executive Suite, we investigate the relationship of CEOs’ political preferences (as reflected in their political contributions) with the prevalence and compensation of women in leadership positions at U.S. public companies. We find that CEOs who favor the Democratic Party (“Democratic CEOs”) are associated with […]
Click here to read the complete post
Posted in Academic Research, Boards of Directors, Comparative Corporate Governance & Regulation, Empirical Research, Executive Compensation, HLS Research
Tagged Boards of Directors, Diversity, Executive Compensation, Executive performance, Executive turnover, Management, Manager characteristics, Political spending
Comments Off on Politics and Gender in the Executive Suite
Insider Trading Risk During the COVID-19 Outbreak
On March 20, 2020, news outlets reported that four U.S. Senators sold millions of dollars in stock following classified briefings to the Senate on the threat of a COVID-19 outbreak. Three days later, the Co-Directors of the Securities and Exchange Commission’s (“SEC”) Division of Enforcement, Stephanie Avakian and Steven Peikin, issued a statement reminding market […]
Click here to read the complete post
Posted in Accounting & Disclosure, Practitioner Publications, Securities Litigation & Enforcement, Securities Regulation
Tagged COVID-19, Information asymmetries, Inside information, Insider trading, Regulation FD, SEC, SEC enforcement, Securities enforcement, Securities regulation
Comments Off on Insider Trading Risk During the COVID-19 Outbreak
Planning for the Possibility that the CEO Tests Positive for COVID-19
At least a dozen CEO’s and CFO’s have tested positive for Covid-19 in the past few weeks. Many have chosen to post or email letters to their employees explaining how they are doing, whether they feel well enough to be running the company and if not, who is in charge. The president of Harvard Larry […]
Click here to read the complete post
Posted in Accounting & Disclosure, Practitioner Publications
Tagged COVID-19, Disclosure, Human capital, Management, Regulation FD, Risk, Risk management, Shocks
1 Comment
The Activism Vulnerability Report Q4 2019
Introduction and Market Update In this Activism Vulnerability Report, FTI has identified the industries that are most susceptible to shareholder activism in the U.S. and Canada according to the Activism Screener’s results. The Activism Vulnerability Report, and the Activism Screener itself, are intended to assist our public company clients and their outside advisors in determining […]
Click here to read the complete post
Posted in Institutional Investors, Mergers & Acquisitions, Practitioner Publications
Tagged COVID-19, Hedge funds, Institutional Investors, Mergers & acquisitions, Shareholder activism
Comments Off on The Activism Vulnerability Report Q4 2019
Corporate Governance Through Exit and Voice
A Clinical Study of Investment Manager Stewardship In a series of previous posts Bebchuk, Cohen and Hirst (discussed on the Forum here, here and here) have argued that investment managers have little incentive to monitor and engage with their portfolio companies. They present evidence collected from public sources to show that index funds in particular […]
Click here to read the complete post
Posted in Academic Research, Empirical Research, ESG, Institutional Investors, International Corporate Governance & Regulation
Tagged Asset management, Engagement, ESG, Exit, Index funds, Institutional Investors, International governance, Stewardship, UK
Comments Off on Corporate Governance Through Exit and Voice
Issuance of Equity to the US Government in Exchange for Aid—Considerations for Boards
Amid the growing economic fallout of the COVID-19 pandemic, the White House’s top economic adviser, Larry Kudlow, signaled earlier this month that the Trump Administration was considering taking equity stakes in coronavirus-impacted companies as a condition to providing economic assistance—“equity for a bailout” in the common parlance. Though contrary to established conservative orthodoxy, which has […]
Click here to read the complete post
Posted in Bankruptcy & Financial Distress, Boards of Directors, Practitioner Publications, Securities Regulation
Tagged Bailouts, Bankruptcy, Boards of Directors, CARES Act, Distressed companies, Equity capital, Equity securities, Financial crisis, Ownership, Securities regulation, Stakeholders
Comments Off on Issuance of Equity to the US Government in Exchange for Aid—Considerations for Boards
The Impact of COVID19 on Shareholder Activism
The ultimate impact of the coronavirus (COVID-19) pandemic on shareholder activism remains largely uncertain and comparisons with the surge in activism that followed the 2008 global financial crisis are tempting, but suspect as it remains questionable whether activists can continue to rely on the same forces that were driving activism prior to COVID-19. In any […]
Click here to read the complete post
Posted in Mergers & Acquisitions, Practitioner Publications, Private Equity
Tagged COVID-19, Firm valuation, Hedge funds, Mergers & acquisitions, Private equity, Settlements, Shareholder activism, Target firms
Comments Off on The Impact of COVID19 on Shareholder Activism
Government Ownership in the Post Virus World
Arguably the single most awaited economic event of 2019 was the public listing of the Saudi national oil company, Saudi Aramco, which swiftly became the largest listed company globally, overtaking Apple. Only half a year later, the privatisation of any state-owned company appears unthinkable. Indeed, the privatization mantra that has underpinned liberal economic thinking and […]
Click here to read the complete post
Posted in International Corporate Governance & Regulation, Practitioner Publications
Tagged China, COVID-19, EU, Europe, Institutional Investors, International governance, Ownership
Comments Off on Government Ownership in the Post Virus World
Poison Pills and Coronavirus: Understanding Glass Lewis’ Contextual Policy Approach
Companies around the world are grappling with the substantial challenges of the COVID-19 pandemic, which continues to wreak havoc on our daily lives and the global economy. The financial outlook changes daily, with an unprecedented number of companies impacted by supply chain disruption, suppressed revenues, limited cash flows and sharply depressed stock prices. These dire […]
Click here to read the complete post
Posted in Boards of Directors, Corporate Elections & Voting, Institutional Investors, Mergers & Acquisitions
Tagged Boards of Directors, COVID-19, Institutional Investors, Mergers & acquisitions, Poison pills, Proxy advisors, Shareholder activism, Shareholder voting, Takeover defenses
Comments Off on Poison Pills and Coronavirus: Understanding Glass Lewis’ Contextual Policy Approach